Placeholder Banner

BIO Thanks Senators for Supporting Higher RFS Volumes

June 24, 2016

The Biotechnology Innovation Organization (BIO) today thanked a bipartisan group of 39 Senators for urging EPA to get the Renewable Fuel Standard (RFS) “back on track by setting blending targets where Congress intended and by removing the distribution waiver.” In particular, BIO thanked Sens. Charles Grassley (R-IA), Amy Klobuchar (D-MN), John Thune (R-SD), Dick Durbin (D-IL), Al Franken (D-MN), and Mark Kirk (R-IL).

Brent Erickson, Executive Vice President of BIO’s Industrial & Environmental Section, stated:

“BIO greatly appreciates the 39 Senators who have urged EPA to ensure that its final rule for 2017 promotes growth in the biofuel sector and captures economic opportunities here in the United States. The Senators understand that EPA’s waiver of RFS volumes in 2014, 2015 and 2016 continues to cause biofuel investment to fall.

“EPA acknowledges that its delays in rulemaking undercut investment in advanced biofuels. It fails to recognize, however, that its methodology continues to discourage investment in advanced biofuels. Investment patterns clearly demonstrate that EPA is sending a sustained market signal that disincentivizes advanced biofuels, causing a $22.4 billion shortfall in necessary investment.

“EPA must correct course in the final 2017 rule and ensure that the U.S. transportation fuel market is open to every gallon of renewable fuel that can be produced.”

The original letter can be found at: http://www.grassley.senate.gov/news/news-releases/epa-finalizes-rule-grassley-klobuchar-lead-bipartisan-group-39-senators-calling.

Discover More
BIO to Transition Agricultural and Environmental Biotech Workstreams  Key Senior Hires Bolster Focus on Regulatory Affairs, Emerging Companies   and Economic Growth   Washington, DC, May 28, 2025 – The Biotechnology Innovation…
“Most favored nation is a deeply flawed proposal that would devastate our nation’s small- and mid-size biotech companies – the very companies that are the leading drivers of medical innovation in the United States and the cornerstone of America’s…
WASHINGTON, DC, April 8, 2025 – Today, the National Security Commission on Emerging Biotechnology (NSCEB), a bipartisan legislative commission established by Congress, issued its much-anticipated report detailing how the United States risks…